These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Applying label-free dynamic mass redistribution assay for studying endogenous FPR1 receptor signalling in human neutrophils. Christensen HB; Gloriam DE; Pedersen DS; Cowland JB; Borregaard N; Bräuner-Osborne H J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):72-78. PubMed ID: 28716665 [TBL] [Abstract][Full Text] [Related]
24. Highlights and hot topics in GPCR research from 'Down Under'. Smith NJ; May LT; Grimsey NL Br J Pharmacol; 2024 Jul; 181(14):2091-2094. PubMed ID: 38798136 [TBL] [Abstract][Full Text] [Related]
25. A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead. Winther M; Gabl M; Welin A; Dahlgren C; Forsman H FEBS Lett; 2015 Jul; 589(15):1832-9. PubMed ID: 26071379 [TBL] [Abstract][Full Text] [Related]
26. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils. Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933 [TBL] [Abstract][Full Text] [Related]
27. Unravelling G protein-coupled receptor signalling networks using global phosphoproteomics. Pokhrel R; Morgan AL; Robinson HR; Stone MJ; Foster SR Br J Pharmacol; 2024 Jul; 181(14):2359-2370. PubMed ID: 36772927 [TBL] [Abstract][Full Text] [Related]
28. Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia. Wei L; Tokizane K; Konishi H; Yu HR; Kiyama H J Neuroinflammation; 2017 Oct; 14(1):198. PubMed ID: 28974234 [TBL] [Abstract][Full Text] [Related]
30. GPCR signalling from within the cell. Jong YI; Harmon SK; O'Malley KL Br J Pharmacol; 2018 Nov; 175(21):4026-4035. PubMed ID: 28872669 [TBL] [Abstract][Full Text] [Related]
31. G-protein-coupled formyl peptide receptors play a dual role in neutrophil chemotaxis and bacterial phagocytosis. Wen X; Xu X; Sun W; Chen K; Pan M; Wang JM; Bolland SM; Jin T Mol Biol Cell; 2019 Feb; 30(3):346-356. PubMed ID: 30540534 [TBL] [Abstract][Full Text] [Related]
32. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1. Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191 [TBL] [Abstract][Full Text] [Related]
33. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils. Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087 [TBL] [Abstract][Full Text] [Related]
34. The FPR2-induced rise in cytosolic calcium in human neutrophils relies on an emptying of intracellular calcium stores and is inhibited by a gelsolin-derived PIP2-binding peptide. Forsman H; Dahlgren C BMC Cell Biol; 2010 Jul; 11():52. PubMed ID: 20602801 [TBL] [Abstract][Full Text] [Related]
35. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop. Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731 [TBL] [Abstract][Full Text] [Related]
36. Pro-phagocytic function and structural basis of GPR84 signaling. Zhang X; Wang Y; Supekar S; Cao X; Zhou J; Dang J; Chen S; Jenkins L; Marsango S; Li X; Liu G; Milligan G; Feng M; Fan H; Gong W; Zhang C Nat Commun; 2023 Sep; 14(1):5706. PubMed ID: 37709767 [TBL] [Abstract][Full Text] [Related]
38. GPR84 regulates pulmonary inflammation by modulating neutrophil functions. Wang SW; Zhang Q; Lu D; Fang YC; Yan XC; Chen J; Xia ZK; Yuan QT; Chen LH; Zhang YM; Nan FJ; Xie X Acta Pharmacol Sin; 2023 Aug; 44(8):1665-1675. PubMed ID: 37016043 [TBL] [Abstract][Full Text] [Related]
39. Signalling in response to sub-picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity. Civciristov S; Halls ML Br J Pharmacol; 2019 Jul; 176(14):2382-2401. PubMed ID: 30801691 [TBL] [Abstract][Full Text] [Related]
40. Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question. Winther M; Holdfeldt A; Sundqvist M; Rajabkhani Z; Gabl M; Bylund J; Dahlgren C; Forsman H PLoS One; 2017; 12(9):e0185132. PubMed ID: 28934373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]